Covid: Remdesivir ‘has little or no impact’ on survival, says WHO


For its Solidarity scientific trial, the WHO examined the results 4 potential therapies – remdesivir, an Ebola drug, was one, however additionally they checked out malaria drug hydroxychloroquine, auto-immune drug interferon, and the HIV drug mixture of lopinavir and ritonavir.